nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoposide—Topoisomerase Inhibitors—Epirubicin—liver cancer	0.219	0.519	CiPCiCtD
Etoposide—Topoisomerase Inhibitors—Doxorubicin—liver cancer	0.202	0.481	CiPCiCtD
Etoposide—lung cancer—liver cancer	0.106	0.503	CtDrD
Etoposide—sarcoma—liver cancer	0.105	0.497	CtDrD
Etoposide—GSTP1—liver cancer	0.0854	0.661	CbGaD
Etoposide—CYP2E1—liver cancer	0.0438	0.339	CbGaD
Etoposide—TOP2A—Epirubicin—liver cancer	0.0222	0.141	CbGbCtD
Etoposide—ABCC6—Doxorubicin—liver cancer	0.0222	0.141	CbGbCtD
Etoposide—ABCC10—Doxorubicin—liver cancer	0.017	0.107	CbGbCtD
Etoposide—UGT1A1—Sorafenib—liver cancer	0.0131	0.0832	CbGbCtD
Etoposide—ABCC1—Epirubicin—liver cancer	0.0123	0.0781	CbGbCtD
Etoposide—TOP2A—Doxorubicin—liver cancer	0.0118	0.0749	CbGbCtD
Etoposide—ABCC3—Doxorubicin—liver cancer	0.0107	0.0676	CbGbCtD
Etoposide—ABCC2—Sorafenib—liver cancer	0.00799	0.0506	CbGbCtD
Etoposide—ABCG2—Sorafenib—liver cancer	0.00722	0.0458	CbGbCtD
Etoposide—ABCC1—Doxorubicin—liver cancer	0.00655	0.0415	CbGbCtD
Etoposide—ABCC2—bile canaliculus—liver cancer	0.00572	0.371	CbGeAlD
Etoposide—ABCC2—Doxorubicin—liver cancer	0.00484	0.0307	CbGbCtD
Etoposide—ABCG2—Doxorubicin—liver cancer	0.00438	0.0278	CbGbCtD
Etoposide—CYP3A5—Sorafenib—liver cancer	0.004	0.0254	CbGbCtD
Etoposide—CYP2C8—Sorafenib—liver cancer	0.00385	0.0244	CbGbCtD
Etoposide—CYP1A2—Sorafenib—liver cancer	0.00298	0.0189	CbGbCtD
Etoposide—ABCB1—Sorafenib—liver cancer	0.0026	0.0165	CbGbCtD
Etoposide—ABCC3—bile duct—liver cancer	0.00224	0.145	CbGeAlD
Etoposide—ABCC2—bile duct—liver cancer	0.00179	0.116	CbGeAlD
Etoposide—ABCB1—Doxorubicin—liver cancer	0.00158	0.01	CbGbCtD
Etoposide—CYP3A4—Sorafenib—liver cancer	0.00156	0.00989	CbGbCtD
Etoposide—ABCC2—bile—liver cancer	0.00137	0.089	CbGeAlD
Etoposide—CYP3A4—Doxorubicin—liver cancer	0.000946	0.006	CbGbCtD
Etoposide—TOP2B—embryo—liver cancer	0.000481	0.0312	CbGeAlD
Etoposide—ABCC3—gall bladder—liver cancer	0.000477	0.0309	CbGeAlD
Etoposide—GSTP1—gall bladder—liver cancer	0.000475	0.0308	CbGeAlD
Etoposide—GSTT1—liver—liver cancer	0.000302	0.0196	CbGeAlD
Etoposide—GSTP1—embryo—liver cancer	0.000301	0.0195	CbGeAlD
Etoposide—ABCC6—liver—liver cancer	0.000245	0.0159	CbGeAlD
Etoposide—TOP2B—liver—liver cancer	0.000222	0.0144	CbGeAlD
Etoposide—PTGS2—gall bladder—liver cancer	0.000222	0.0144	CbGeAlD
Etoposide—UGT1A1—liver—liver cancer	0.000177	0.0115	CbGeAlD
Etoposide—PTGS2—embryo—liver cancer	0.000141	0.00911	CbGeAlD
Etoposide—ABCC3—liver—liver cancer	0.00014	0.00907	CbGeAlD
Etoposide—GSTP1—liver—liver cancer	0.000139	0.00903	CbGeAlD
Etoposide—ABCC10—liver—liver cancer	0.000139	0.00902	CbGeAlD
Etoposide—Infestation—Sorafenib—liver cancer	0.000136	0.0041	CcSEcCtD
Etoposide—Infestation NOS—Sorafenib—liver cancer	0.000136	0.0041	CcSEcCtD
Etoposide—Optic neuritis—Doxorubicin—liver cancer	0.000135	0.00407	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.000134	0.00406	CcSEcCtD
Etoposide—Acute coronary syndrome—Sorafenib—liver cancer	0.000134	0.00404	CcSEcCtD
Etoposide—Renal failure—Sorafenib—liver cancer	0.000133	0.00403	CcSEcCtD
Etoposide—Myocardial infarction—Sorafenib—liver cancer	0.000133	0.00402	CcSEcCtD
Etoposide—Neuropathy peripheral—Sorafenib—liver cancer	0.000133	0.00402	CcSEcCtD
Etoposide—Jaundice—Sorafenib—liver cancer	0.000132	0.00399	CcSEcCtD
Etoposide—Stomatitis—Sorafenib—liver cancer	0.000132	0.00399	CcSEcCtD
Etoposide—Hepatobiliary disease—Sorafenib—liver cancer	0.000128	0.00387	CcSEcCtD
Etoposide—Nail disorder—Doxorubicin—liver cancer	0.000128	0.00386	CcSEcCtD
Etoposide—Urinary tract disorder—Sorafenib—liver cancer	0.00012	0.00363	CcSEcCtD
Etoposide—Urethral disorder—Sorafenib—liver cancer	0.000119	0.0036	CcSEcCtD
Etoposide—Erythema multiforme—Sorafenib—liver cancer	0.000115	0.00348	CcSEcCtD
Etoposide—Necrosis—Epirubicin—liver cancer	0.000114	0.00345	CcSEcCtD
Etoposide—Cardiac disorder—Sorafenib—liver cancer	0.000113	0.00341	CcSEcCtD
Etoposide—Flushing—Sorafenib—liver cancer	0.000113	0.00341	CcSEcCtD
Etoposide—ABCC2—liver—liver cancer	0.000112	0.00724	CbGeAlD
Etoposide—TOP2A—Daunorubicin—Epirubicin—liver cancer	0.000111	0.173	CbGdCrCtD
Etoposide—TOP2A—Idarubicin—Epirubicin—liver cancer	0.000111	0.173	CbGdCrCtD
Etoposide—TOP2A—Doxorubicin—Epirubicin—liver cancer	0.000111	0.173	CbGdCrCtD
Etoposide—Angiopathy—Sorafenib—liver cancer	0.00011	0.00334	CcSEcCtD
Etoposide—Immune system disorder—Sorafenib—liver cancer	0.00011	0.00332	CcSEcCtD
Etoposide—Rigors—Epirubicin—liver cancer	0.00011	0.00331	CcSEcCtD
Etoposide—Mediastinal disorder—Sorafenib—liver cancer	0.00011	0.00331	CcSEcCtD
Etoposide—Alopecia—Sorafenib—liver cancer	0.000107	0.00325	CcSEcCtD
Etoposide—Necrosis—Doxorubicin—liver cancer	0.000106	0.00319	CcSEcCtD
Etoposide—Dysgeusia—Sorafenib—liver cancer	0.000104	0.00313	CcSEcCtD
Etoposide—Extravasation—Epirubicin—liver cancer	0.000103	0.0031	CcSEcCtD
Etoposide—TOP2A—Epirubicin—Doxorubicin—liver cancer	0.000102	0.16	CbGdCrCtD
Etoposide—TOP2A—Idarubicin—Doxorubicin—liver cancer	0.000102	0.16	CbGdCrCtD
Etoposide—TOP2A—Daunorubicin—Doxorubicin—liver cancer	0.000102	0.16	CbGdCrCtD
Etoposide—Cardiovascular disorder—Epirubicin—liver cancer	0.000102	0.00308	CcSEcCtD
Etoposide—Muscle spasms—Sorafenib—liver cancer	0.000102	0.00308	CcSEcCtD
Etoposide—Rigors—Doxorubicin—liver cancer	0.000101	0.00307	CcSEcCtD
Etoposide—Skin discolouration—Epirubicin—liver cancer	9.91e-05	0.003	CcSEcCtD
Etoposide—ABCC1—liver—liver cancer	9.85e-05	0.00638	CbGeAlD
Etoposide—Cellulitis—Epirubicin—liver cancer	9.84e-05	0.00298	CcSEcCtD
Etoposide—Anaemia—Sorafenib—liver cancer	9.79e-05	0.00296	CcSEcCtD
Etoposide—Hyperuricaemia—Epirubicin—liver cancer	9.65e-05	0.00292	CcSEcCtD
Etoposide—Extravasation—Doxorubicin—liver cancer	9.49e-05	0.00287	CcSEcCtD
Etoposide—Leukopenia—Sorafenib—liver cancer	9.48e-05	0.00287	CcSEcCtD
Etoposide—Ulcer—Epirubicin—liver cancer	9.47e-05	0.00286	CcSEcCtD
Etoposide—Cardiovascular disorder—Doxorubicin—liver cancer	9.43e-05	0.00285	CcSEcCtD
Etoposide—Loss of consciousness—Sorafenib—liver cancer	9.31e-05	0.00281	CcSEcCtD
Etoposide—Cough—Sorafenib—liver cancer	9.24e-05	0.00279	CcSEcCtD
Etoposide—Inflammation—Epirubicin—liver cancer	9.23e-05	0.00279	CcSEcCtD
Etoposide—Skin discolouration—Doxorubicin—liver cancer	9.17e-05	0.00277	CcSEcCtD
Etoposide—Hypertension—Sorafenib—liver cancer	9.14e-05	0.00276	CcSEcCtD
Etoposide—Blood uric acid increased—Epirubicin—liver cancer	9.12e-05	0.00276	CcSEcCtD
Etoposide—Cellulitis—Doxorubicin—liver cancer	9.11e-05	0.00275	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	8.95e-05	0.00271	CcSEcCtD
Etoposide—Phosphatase alkaline increased—Epirubicin—liver cancer	8.95e-05	0.00271	CcSEcCtD
Etoposide—Hyperuricaemia—Doxorubicin—liver cancer	8.93e-05	0.0027	CcSEcCtD
Etoposide—Ulcer—Doxorubicin—liver cancer	8.76e-05	0.00265	CcSEcCtD
Etoposide—ABCB1—embryo—liver cancer	8.69e-05	0.00563	CbGeAlD
Etoposide—Anaphylactic shock—Sorafenib—liver cancer	8.64e-05	0.00261	CcSEcCtD
Etoposide—Infection—Sorafenib—liver cancer	8.59e-05	0.0026	CcSEcCtD
Etoposide—Skin exfoliation—Epirubicin—liver cancer	8.55e-05	0.00258	CcSEcCtD
Etoposide—Candida infection—Epirubicin—liver cancer	8.55e-05	0.00258	CcSEcCtD
Etoposide—Inflammation—Doxorubicin—liver cancer	8.54e-05	0.00258	CcSEcCtD
Etoposide—Thrombocytopenia—Sorafenib—liver cancer	8.46e-05	0.00256	CcSEcCtD
Etoposide—Blood uric acid increased—Doxorubicin—liver cancer	8.44e-05	0.00255	CcSEcCtD
Etoposide—Neuropathy—Epirubicin—liver cancer	8.41e-05	0.00254	CcSEcCtD
Etoposide—Skin disorder—Sorafenib—liver cancer	8.39e-05	0.00254	CcSEcCtD
Etoposide—CYP2C8—liver—liver cancer	8.39e-05	0.00543	CbGeAlD
Etoposide—Phosphatase alkaline increased—Doxorubicin—liver cancer	8.28e-05	0.0025	CcSEcCtD
Etoposide—Anorexia—Sorafenib—liver cancer	8.24e-05	0.00249	CcSEcCtD
Etoposide—Oesophagitis—Epirubicin—liver cancer	8.18e-05	0.00247	CcSEcCtD
Etoposide—ABCG2—liver—liver cancer	8.15e-05	0.00528	CbGeAlD
Etoposide—Rash maculo-papular—Epirubicin—liver cancer	8.14e-05	0.00246	CcSEcCtD
Etoposide—Mouth ulceration—Epirubicin—liver cancer	8.09e-05	0.00245	CcSEcCtD
Etoposide—Skin exfoliation—Doxorubicin—liver cancer	7.91e-05	0.00239	CcSEcCtD
Etoposide—Candida infection—Doxorubicin—liver cancer	7.91e-05	0.00239	CcSEcCtD
Etoposide—CYP1A2—liver—liver cancer	7.85e-05	0.00508	CbGeAlD
Etoposide—Neuropathy—Doxorubicin—liver cancer	7.78e-05	0.00235	CcSEcCtD
Etoposide—Sepsis—Epirubicin—liver cancer	7.77e-05	0.00235	CcSEcCtD
Etoposide—Dyspnoea—Sorafenib—liver cancer	7.71e-05	0.00233	CcSEcCtD
Etoposide—Oesophagitis—Doxorubicin—liver cancer	7.57e-05	0.00229	CcSEcCtD
Etoposide—CYP3A5—liver—liver cancer	7.57e-05	0.0049	CbGeAlD
Etoposide—Phlebitis—Epirubicin—liver cancer	7.54e-05	0.00228	CcSEcCtD
Etoposide—Rash maculo-papular—Doxorubicin—liver cancer	7.53e-05	0.00228	CcSEcCtD
Etoposide—Decreased appetite—Sorafenib—liver cancer	7.51e-05	0.00227	CcSEcCtD
Etoposide—Mouth ulceration—Doxorubicin—liver cancer	7.49e-05	0.00226	CcSEcCtD
Etoposide—Blood alkaline phosphatase increased—Epirubicin—liver cancer	7.47e-05	0.00226	CcSEcCtD
Etoposide—Gastrointestinal disorder—Sorafenib—liver cancer	7.46e-05	0.00226	CcSEcCtD
Etoposide—Fatigue—Sorafenib—liver cancer	7.45e-05	0.00225	CcSEcCtD
Etoposide—Pain—Sorafenib—liver cancer	7.39e-05	0.00223	CcSEcCtD
Etoposide—Constipation—Sorafenib—liver cancer	7.39e-05	0.00223	CcSEcCtD
Etoposide—Sepsis—Doxorubicin—liver cancer	7.19e-05	0.00217	CcSEcCtD
Etoposide—Cardiac failure congestive—Epirubicin—liver cancer	7.17e-05	0.00217	CcSEcCtD
Etoposide—Gastrointestinal pain—Sorafenib—liver cancer	7.07e-05	0.00214	CcSEcCtD
Etoposide—CYP2E1—liver—liver cancer	7.06e-05	0.00457	CbGeAlD
Etoposide—Phlebitis—Doxorubicin—liver cancer	6.98e-05	0.00211	CcSEcCtD
Etoposide—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	6.91e-05	0.00209	CcSEcCtD
Etoposide—Urticaria—Sorafenib—liver cancer	6.87e-05	0.00208	CcSEcCtD
Etoposide—Abdominal pain—Sorafenib—liver cancer	6.83e-05	0.00207	CcSEcCtD
Etoposide—Body temperature increased—Sorafenib—liver cancer	6.83e-05	0.00207	CcSEcCtD
Etoposide—Anaphylactoid reaction—Epirubicin—liver cancer	6.71e-05	0.00203	CcSEcCtD
Etoposide—Cardiac failure—Epirubicin—liver cancer	6.66e-05	0.00201	CcSEcCtD
Etoposide—Cardiac failure congestive—Doxorubicin—liver cancer	6.63e-05	0.002	CcSEcCtD
Etoposide—PTGS2—liver—liver cancer	6.5e-05	0.00421	CbGeAlD
Etoposide—Hypersensitivity—Sorafenib—liver cancer	6.37e-05	0.00192	CcSEcCtD
Etoposide—Anaphylactoid reaction—Doxorubicin—liver cancer	6.21e-05	0.00188	CcSEcCtD
Etoposide—Asthenia—Sorafenib—liver cancer	6.2e-05	0.00187	CcSEcCtD
Etoposide—Cardiac arrest—Epirubicin—liver cancer	6.18e-05	0.00187	CcSEcCtD
Etoposide—Cardiac failure—Doxorubicin—liver cancer	6.16e-05	0.00186	CcSEcCtD
Etoposide—Pruritus—Sorafenib—liver cancer	6.11e-05	0.00185	CcSEcCtD
Etoposide—Diarrhoea—Sorafenib—liver cancer	5.91e-05	0.00179	CcSEcCtD
Etoposide—Toxic epidermal necrolysis—Epirubicin—liver cancer	5.85e-05	0.00177	CcSEcCtD
Etoposide—Alanine aminotransferase increased—Epirubicin—liver cancer	5.73e-05	0.00173	CcSEcCtD
Etoposide—Cardiac arrest—Doxorubicin—liver cancer	5.72e-05	0.00173	CcSEcCtD
Etoposide—Dizziness—Sorafenib—liver cancer	5.72e-05	0.00173	CcSEcCtD
Etoposide—CYP3A4—liver—liver cancer	5.68e-05	0.00368	CbGeAlD
Etoposide—Dysphagia—Epirubicin—liver cancer	5.62e-05	0.0017	CcSEcCtD
Etoposide—Vomiting—Sorafenib—liver cancer	5.5e-05	0.00166	CcSEcCtD
Etoposide—Rash—Sorafenib—liver cancer	5.45e-05	0.00165	CcSEcCtD
Etoposide—Dermatitis—Sorafenib—liver cancer	5.44e-05	0.00165	CcSEcCtD
Etoposide—Toxic epidermal necrolysis—Doxorubicin—liver cancer	5.41e-05	0.00164	CcSEcCtD
Etoposide—Headache—Sorafenib—liver cancer	5.41e-05	0.00164	CcSEcCtD
Etoposide—Pancytopenia—Epirubicin—liver cancer	5.33e-05	0.00161	CcSEcCtD
Etoposide—Alanine aminotransferase increased—Doxorubicin—liver cancer	5.3e-05	0.0016	CcSEcCtD
Etoposide—Neutropenia—Epirubicin—liver cancer	5.25e-05	0.00159	CcSEcCtD
Etoposide—Dysphagia—Doxorubicin—liver cancer	5.2e-05	0.00157	CcSEcCtD
Etoposide—Nausea—Sorafenib—liver cancer	5.13e-05	0.00155	CcSEcCtD
Etoposide—Pneumonia—Epirubicin—liver cancer	5.04e-05	0.00152	CcSEcCtD
Etoposide—Infestation—Epirubicin—liver cancer	5.01e-05	0.00151	CcSEcCtD
Etoposide—Infestation NOS—Epirubicin—liver cancer	5.01e-05	0.00151	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Epirubicin—liver cancer	4.97e-05	0.0015	CcSEcCtD
Etoposide—Pancytopenia—Doxorubicin—liver cancer	4.94e-05	0.00149	CcSEcCtD
Etoposide—Renal failure—Epirubicin—liver cancer	4.92e-05	0.00149	CcSEcCtD
Etoposide—Neuropathy peripheral—Epirubicin—liver cancer	4.91e-05	0.00148	CcSEcCtD
Etoposide—Stomatitis—Epirubicin—liver cancer	4.88e-05	0.00148	CcSEcCtD
Etoposide—Jaundice—Epirubicin—liver cancer	4.88e-05	0.00148	CcSEcCtD
Etoposide—Neutropenia—Doxorubicin—liver cancer	4.86e-05	0.00147	CcSEcCtD
Etoposide—Hepatobiliary disease—Epirubicin—liver cancer	4.74e-05	0.00143	CcSEcCtD
Etoposide—Agranulocytosis—Epirubicin—liver cancer	4.67e-05	0.00141	CcSEcCtD
Etoposide—Pneumonia—Doxorubicin—liver cancer	4.66e-05	0.00141	CcSEcCtD
Etoposide—Infestation NOS—Doxorubicin—liver cancer	4.63e-05	0.0014	CcSEcCtD
Etoposide—Infestation—Doxorubicin—liver cancer	4.63e-05	0.0014	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Doxorubicin—liver cancer	4.59e-05	0.00139	CcSEcCtD
Etoposide—Renal failure—Doxorubicin—liver cancer	4.56e-05	0.00138	CcSEcCtD
Etoposide—Neuropathy peripheral—Doxorubicin—liver cancer	4.54e-05	0.00137	CcSEcCtD
Etoposide—Jaundice—Doxorubicin—liver cancer	4.52e-05	0.00137	CcSEcCtD
Etoposide—Stomatitis—Doxorubicin—liver cancer	4.52e-05	0.00137	CcSEcCtD
Etoposide—Hypoaesthesia—Epirubicin—liver cancer	4.47e-05	0.00135	CcSEcCtD
Etoposide—Urinary tract disorder—Epirubicin—liver cancer	4.44e-05	0.00134	CcSEcCtD
Etoposide—Urethral disorder—Epirubicin—liver cancer	4.41e-05	0.00133	CcSEcCtD
Etoposide—Hepatobiliary disease—Doxorubicin—liver cancer	4.38e-05	0.00132	CcSEcCtD
Etoposide—Agranulocytosis—Doxorubicin—liver cancer	4.32e-05	0.00131	CcSEcCtD
Etoposide—Erythema multiforme—Epirubicin—liver cancer	4.25e-05	0.00129	CcSEcCtD
Etoposide—Eye disorder—Epirubicin—liver cancer	4.2e-05	0.00127	CcSEcCtD
Etoposide—Cardiac disorder—Epirubicin—liver cancer	4.17e-05	0.00126	CcSEcCtD
Etoposide—Flushing—Epirubicin—liver cancer	4.17e-05	0.00126	CcSEcCtD
Etoposide—Hypoaesthesia—Doxorubicin—liver cancer	4.14e-05	0.00125	CcSEcCtD
Etoposide—Urinary tract disorder—Doxorubicin—liver cancer	4.11e-05	0.00124	CcSEcCtD
Etoposide—Angiopathy—Epirubicin—liver cancer	4.08e-05	0.00123	CcSEcCtD
Etoposide—Urethral disorder—Doxorubicin—liver cancer	4.08e-05	0.00123	CcSEcCtD
Etoposide—Immune system disorder—Epirubicin—liver cancer	4.06e-05	0.00123	CcSEcCtD
Etoposide—Mediastinal disorder—Epirubicin—liver cancer	4.05e-05	0.00122	CcSEcCtD
Etoposide—Chills—Epirubicin—liver cancer	4.03e-05	0.00122	CcSEcCtD
Etoposide—ABCB1—liver—liver cancer	4.02e-05	0.00261	CbGeAlD
Etoposide—Alopecia—Epirubicin—liver cancer	3.97e-05	0.0012	CcSEcCtD
Etoposide—Erythema multiforme—Doxorubicin—liver cancer	3.93e-05	0.00119	CcSEcCtD
Etoposide—Eye disorder—Doxorubicin—liver cancer	3.89e-05	0.00118	CcSEcCtD
Etoposide—Flushing—Doxorubicin—liver cancer	3.86e-05	0.00117	CcSEcCtD
Etoposide—Cardiac disorder—Doxorubicin—liver cancer	3.86e-05	0.00117	CcSEcCtD
Etoposide—Dysgeusia—Epirubicin—liver cancer	3.83e-05	0.00116	CcSEcCtD
Etoposide—Back pain—Epirubicin—liver cancer	3.79e-05	0.00114	CcSEcCtD
Etoposide—Angiopathy—Doxorubicin—liver cancer	3.77e-05	0.00114	CcSEcCtD
Etoposide—Muscle spasms—Epirubicin—liver cancer	3.76e-05	0.00114	CcSEcCtD
Etoposide—Immune system disorder—Doxorubicin—liver cancer	3.76e-05	0.00114	CcSEcCtD
Etoposide—Mediastinal disorder—Doxorubicin—liver cancer	3.75e-05	0.00113	CcSEcCtD
Etoposide—Chills—Doxorubicin—liver cancer	3.73e-05	0.00113	CcSEcCtD
Etoposide—Alopecia—Doxorubicin—liver cancer	3.68e-05	0.00111	CcSEcCtD
Etoposide—Ill-defined disorder—Epirubicin—liver cancer	3.63e-05	0.0011	CcSEcCtD
Etoposide—Anaemia—Epirubicin—liver cancer	3.62e-05	0.00109	CcSEcCtD
Etoposide—Dysgeusia—Doxorubicin—liver cancer	3.55e-05	0.00107	CcSEcCtD
Etoposide—Malaise—Epirubicin—liver cancer	3.53e-05	0.00107	CcSEcCtD
Etoposide—Vertigo—Epirubicin—liver cancer	3.52e-05	0.00106	CcSEcCtD
Etoposide—Leukopenia—Epirubicin—liver cancer	3.5e-05	0.00106	CcSEcCtD
Etoposide—Back pain—Doxorubicin—liver cancer	3.5e-05	0.00106	CcSEcCtD
Etoposide—Muscle spasms—Doxorubicin—liver cancer	3.48e-05	0.00105	CcSEcCtD
Etoposide—Loss of consciousness—Epirubicin—liver cancer	3.44e-05	0.00104	CcSEcCtD
Etoposide—Cough—Epirubicin—liver cancer	3.42e-05	0.00103	CcSEcCtD
Etoposide—Convulsion—Epirubicin—liver cancer	3.39e-05	0.00103	CcSEcCtD
Etoposide—Hypertension—Epirubicin—liver cancer	3.38e-05	0.00102	CcSEcCtD
Etoposide—Ill-defined disorder—Doxorubicin—liver cancer	3.36e-05	0.00102	CcSEcCtD
Etoposide—Anaemia—Doxorubicin—liver cancer	3.35e-05	0.00101	CcSEcCtD
Etoposide—Chest pain—Epirubicin—liver cancer	3.33e-05	0.00101	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	3.31e-05	0.001	CcSEcCtD
Etoposide—Discomfort—Epirubicin—liver cancer	3.29e-05	0.000995	CcSEcCtD
Etoposide—Malaise—Doxorubicin—liver cancer	3.27e-05	0.000987	CcSEcCtD
Etoposide—Vertigo—Doxorubicin—liver cancer	3.25e-05	0.000984	CcSEcCtD
Etoposide—Leukopenia—Doxorubicin—liver cancer	3.24e-05	0.00098	CcSEcCtD
Etoposide—Confusional state—Epirubicin—liver cancer	3.22e-05	0.000974	CcSEcCtD
Etoposide—Anaphylactic shock—Epirubicin—liver cancer	3.19e-05	0.000966	CcSEcCtD
Etoposide—Loss of consciousness—Doxorubicin—liver cancer	3.18e-05	0.000962	CcSEcCtD
Etoposide—Infection—Epirubicin—liver cancer	3.17e-05	0.000959	CcSEcCtD
Etoposide—Cough—Doxorubicin—liver cancer	3.16e-05	0.000955	CcSEcCtD
Etoposide—Convulsion—Doxorubicin—liver cancer	3.14e-05	0.000948	CcSEcCtD
Etoposide—Thrombocytopenia—Epirubicin—liver cancer	3.13e-05	0.000945	CcSEcCtD
Etoposide—Hypertension—Doxorubicin—liver cancer	3.13e-05	0.000945	CcSEcCtD
Etoposide—Tachycardia—Epirubicin—liver cancer	3.12e-05	0.000942	CcSEcCtD
Etoposide—Skin disorder—Epirubicin—liver cancer	3.1e-05	0.000938	CcSEcCtD
Etoposide—Hyperhidrosis—Epirubicin—liver cancer	3.09e-05	0.000933	CcSEcCtD
Etoposide—Chest pain—Doxorubicin—liver cancer	3.08e-05	0.000932	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	3.06e-05	0.000926	CcSEcCtD
Etoposide—Discomfort—Doxorubicin—liver cancer	3.05e-05	0.000921	CcSEcCtD
Etoposide—Anorexia—Epirubicin—liver cancer	3.04e-05	0.00092	CcSEcCtD
Etoposide—Hypotension—Epirubicin—liver cancer	2.98e-05	0.000902	CcSEcCtD
Etoposide—Confusional state—Doxorubicin—liver cancer	2.98e-05	0.000901	CcSEcCtD
Etoposide—Anaphylactic shock—Doxorubicin—liver cancer	2.96e-05	0.000893	CcSEcCtD
Etoposide—Infection—Doxorubicin—liver cancer	2.94e-05	0.000888	CcSEcCtD
Etoposide—Thrombocytopenia—Doxorubicin—liver cancer	2.89e-05	0.000875	CcSEcCtD
Etoposide—Tachycardia—Doxorubicin—liver cancer	2.88e-05	0.000872	CcSEcCtD
Etoposide—Skin disorder—Doxorubicin—liver cancer	2.87e-05	0.000868	CcSEcCtD
Etoposide—Paraesthesia—Epirubicin—liver cancer	2.87e-05	0.000867	CcSEcCtD
Etoposide—Hyperhidrosis—Doxorubicin—liver cancer	2.86e-05	0.000864	CcSEcCtD
Etoposide—Dyspnoea—Epirubicin—liver cancer	2.85e-05	0.000861	CcSEcCtD
Etoposide—Somnolence—Epirubicin—liver cancer	2.84e-05	0.000858	CcSEcCtD
Etoposide—Anorexia—Doxorubicin—liver cancer	2.82e-05	0.000852	CcSEcCtD
Etoposide—Decreased appetite—Epirubicin—liver cancer	2.78e-05	0.000839	CcSEcCtD
Etoposide—Hypotension—Doxorubicin—liver cancer	2.76e-05	0.000835	CcSEcCtD
Etoposide—Gastrointestinal disorder—Epirubicin—liver cancer	2.76e-05	0.000834	CcSEcCtD
Etoposide—Fatigue—Epirubicin—liver cancer	2.75e-05	0.000832	CcSEcCtD
Etoposide—Constipation—Epirubicin—liver cancer	2.73e-05	0.000826	CcSEcCtD
Etoposide—Pain—Epirubicin—liver cancer	2.73e-05	0.000826	CcSEcCtD
Etoposide—Paraesthesia—Doxorubicin—liver cancer	2.65e-05	0.000802	CcSEcCtD
Etoposide—Dyspnoea—Doxorubicin—liver cancer	2.63e-05	0.000797	CcSEcCtD
Etoposide—Feeling abnormal—Epirubicin—liver cancer	2.63e-05	0.000796	CcSEcCtD
Etoposide—Somnolence—Doxorubicin—liver cancer	2.63e-05	0.000794	CcSEcCtD
Etoposide—Gastrointestinal pain—Epirubicin—liver cancer	2.61e-05	0.00079	CcSEcCtD
Etoposide—Decreased appetite—Doxorubicin—liver cancer	2.57e-05	0.000777	CcSEcCtD
Etoposide—Gastrointestinal disorder—Doxorubicin—liver cancer	2.55e-05	0.000771	CcSEcCtD
Etoposide—Fatigue—Doxorubicin—liver cancer	2.55e-05	0.00077	CcSEcCtD
Etoposide—Urticaria—Epirubicin—liver cancer	2.54e-05	0.000767	CcSEcCtD
Etoposide—Pain—Doxorubicin—liver cancer	2.53e-05	0.000764	CcSEcCtD
Etoposide—Constipation—Doxorubicin—liver cancer	2.53e-05	0.000764	CcSEcCtD
Etoposide—Abdominal pain—Epirubicin—liver cancer	2.52e-05	0.000763	CcSEcCtD
Etoposide—Body temperature increased—Epirubicin—liver cancer	2.52e-05	0.000763	CcSEcCtD
Etoposide—Feeling abnormal—Doxorubicin—liver cancer	2.44e-05	0.000736	CcSEcCtD
Etoposide—Gastrointestinal pain—Doxorubicin—liver cancer	2.42e-05	0.000731	CcSEcCtD
Etoposide—Hypersensitivity—Epirubicin—liver cancer	2.35e-05	0.000711	CcSEcCtD
Etoposide—Urticaria—Doxorubicin—liver cancer	2.35e-05	0.00071	CcSEcCtD
Etoposide—Abdominal pain—Doxorubicin—liver cancer	2.34e-05	0.000706	CcSEcCtD
Etoposide—Body temperature increased—Doxorubicin—liver cancer	2.34e-05	0.000706	CcSEcCtD
Etoposide—Asthenia—Epirubicin—liver cancer	2.29e-05	0.000693	CcSEcCtD
Etoposide—Pruritus—Epirubicin—liver cancer	2.26e-05	0.000683	CcSEcCtD
Etoposide—Diarrhoea—Epirubicin—liver cancer	2.19e-05	0.000661	CcSEcCtD
Etoposide—Hypersensitivity—Doxorubicin—liver cancer	2.18e-05	0.000658	CcSEcCtD
Etoposide—Asthenia—Doxorubicin—liver cancer	2.12e-05	0.000641	CcSEcCtD
Etoposide—Dizziness—Epirubicin—liver cancer	2.11e-05	0.000639	CcSEcCtD
Etoposide—Pruritus—Doxorubicin—liver cancer	2.09e-05	0.000632	CcSEcCtD
Etoposide—Vomiting—Epirubicin—liver cancer	2.03e-05	0.000614	CcSEcCtD
Etoposide—Diarrhoea—Doxorubicin—liver cancer	2.02e-05	0.000611	CcSEcCtD
Etoposide—Rash—Epirubicin—liver cancer	2.01e-05	0.000609	CcSEcCtD
Etoposide—Dermatitis—Epirubicin—liver cancer	2.01e-05	0.000608	CcSEcCtD
Etoposide—Headache—Epirubicin—liver cancer	2e-05	0.000605	CcSEcCtD
Etoposide—Dizziness—Doxorubicin—liver cancer	1.95e-05	0.000591	CcSEcCtD
Etoposide—Nausea—Epirubicin—liver cancer	1.9e-05	0.000574	CcSEcCtD
Etoposide—Vomiting—Doxorubicin—liver cancer	1.88e-05	0.000568	CcSEcCtD
Etoposide—Rash—Doxorubicin—liver cancer	1.86e-05	0.000563	CcSEcCtD
Etoposide—Dermatitis—Doxorubicin—liver cancer	1.86e-05	0.000563	CcSEcCtD
Etoposide—Headache—Doxorubicin—liver cancer	1.85e-05	0.00056	CcSEcCtD
Etoposide—Nausea—Doxorubicin—liver cancer	1.76e-05	0.000531	CcSEcCtD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.84e-06	5.78e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PPARA—liver cancer	1.81e-06	5.71e-05	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	1.8e-06	5.65e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.79e-06	5.64e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—GSTM1—liver cancer	1.77e-06	5.56e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—CYP1A1—liver cancer	1.75e-06	5.49e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—BRAF—liver cancer	1.74e-06	5.48e-05	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PIK3CD—liver cancer	1.74e-06	5.48e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—CYP2E1—liver cancer	1.74e-06	5.47e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—CYCS—liver cancer	1.73e-06	5.45e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GSTA4—liver cancer	1.73e-06	5.44e-05	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—ALB—liver cancer	1.72e-06	5.41e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—GGT1—liver cancer	1.7e-06	5.35e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—GOT1—liver cancer	1.7e-06	5.35e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.69e-06	5.32e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GSTA2—liver cancer	1.69e-06	5.3e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—CYP1A1—liver cancer	1.68e-06	5.27e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.67e-06	5.27e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.65e-06	5.2e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PSMA4—liver cancer	1.65e-06	5.18e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PSMD10—liver cancer	1.65e-06	5.18e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—H2AFX—liver cancer	1.63e-06	5.14e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—CYCS—liver cancer	1.63e-06	5.13e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—PIK3CD—liver cancer	1.63e-06	5.13e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.63e-06	5.12e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—CYCS—liver cancer	1.63e-06	5.12e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GSTA1—liver cancer	1.63e-06	5.12e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—MTHFR—liver cancer	1.63e-06	5.12e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—SERPINE1—liver cancer	1.61e-06	5.07e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PIK3CG—liver cancer	1.61e-06	5.07e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—HPGDS—liver cancer	1.61e-06	5.07e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—NAT2—liver cancer	1.61e-06	5.06e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GOT2—liver cancer	1.6e-06	5.04e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—GGT1—liver cancer	1.6e-06	5.04e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—GOT1—liver cancer	1.6e-06	5.04e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—GGT1—liver cancer	1.6e-06	5.03e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—GOT1—liver cancer	1.6e-06	5.03e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PPARA—liver cancer	1.6e-06	5.02e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—MTHFR—liver cancer	1.56e-06	4.92e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PPARG—liver cancer	1.56e-06	4.89e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PIK3CG—liver cancer	1.55e-06	4.89e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.55e-06	4.87e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ALDOB—liver cancer	1.54e-06	4.85e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CPT1B—liver cancer	1.54e-06	4.84e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GLUL—liver cancer	1.54e-06	4.84e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PPARA—liver cancer	1.53e-06	4.82e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—GSTP1—liver cancer	1.53e-06	4.81e-05	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PIK3CB—liver cancer	1.52e-06	4.78e-05	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	1.52e-06	4.77e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CYP2E1—liver cancer	1.51e-06	4.74e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—HMOX1—liver cancer	1.51e-06	4.74e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PPARG—liver cancer	1.5e-06	4.72e-05	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—PIK3CA—liver cancer	1.5e-06	4.71e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—NR1H4—liver cancer	1.49e-06	4.67e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MTHFR—liver cancer	1.48e-06	4.66e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—TERT—liver cancer	1.48e-06	4.65e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CRABP1—liver cancer	1.47e-06	4.63e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GSTA3—liver cancer	1.46e-06	4.59e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.46e-06	4.59e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—RAF1—liver cancer	1.46e-06	4.58e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—GSTP1—liver cancer	1.44e-06	4.52e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PSMA4—liver cancer	1.44e-06	4.52e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PSMD10—liver cancer	1.44e-06	4.52e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—GSTP1—liver cancer	1.44e-06	4.51e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—PIK3CB—liver cancer	1.42e-06	4.47e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—MTOR—liver cancer	1.42e-06	4.47e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—HMOX1—liver cancer	1.42e-06	4.46e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PIK3CD—liver cancer	1.42e-06	4.45e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—HMOX1—liver cancer	1.42e-06	4.45e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CYCS—liver cancer	1.41e-06	4.44e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—GSTM1—liver cancer	1.4e-06	4.42e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—ALB—liver cancer	1.4e-06	4.4e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GOT2—liver cancer	1.4e-06	4.39e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GOT1—liver cancer	1.38e-06	4.35e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GGT1—liver cancer	1.38e-06	4.35e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.38e-06	4.33e-05	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	1.37e-06	4.31e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PIK3CG—liver cancer	1.37e-06	4.3e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PIK3CD—liver cancer	1.37e-06	4.3e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—ALB—liver cancer	1.35e-06	4.24e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GSTA4—liver cancer	1.34e-06	4.2e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—CDKN1B—liver cancer	1.33e-06	4.2e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—CYP1A1—liver cancer	1.33e-06	4.19e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.32e-06	4.17e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—GSTM1—liver cancer	1.32e-06	4.16e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PPARG—liver cancer	1.32e-06	4.15e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—GSTM1—liver cancer	1.32e-06	4.15e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CYP2E1—liver cancer	1.31e-06	4.13e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PIK3CG—liver cancer	1.31e-06	4.13e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GSTA2—liver cancer	1.3e-06	4.09e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—HPGDS—liver cancer	1.29e-06	4.04e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.28e-06	4.02e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PPARG—liver cancer	1.27e-06	3.99e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—CTNNB1—liver cancer	1.26e-06	3.96e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GSTA1—liver cancer	1.26e-06	3.95e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—CYP1A1—liver cancer	1.25e-06	3.94e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—CYP1A1—liver cancer	1.25e-06	3.93e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—APC—liver cancer	1.25e-06	3.92e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GSTP1—liver cancer	1.24e-06	3.91e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—NAT2—liver cancer	1.24e-06	3.9e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—MTHFR—liver cancer	1.24e-06	3.9e-05	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	1.24e-06	3.89e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PIK3CB—liver cancer	1.23e-06	3.88e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—CDKN1A—liver cancer	1.23e-06	3.87e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CYCS—liver cancer	1.23e-06	3.86e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—HMOX1—liver cancer	1.23e-06	3.86e-05	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—AKT1—liver cancer	1.22e-06	3.85e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PPARA—liver cancer	1.22e-06	3.83e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GGT1—liver cancer	1.21e-06	3.79e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GOT1—liver cancer	1.21e-06	3.79e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PIK3CD—liver cancer	1.2e-06	3.78e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PIK3CB—liver cancer	1.19e-06	3.74e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ALDOB—liver cancer	1.19e-06	3.74e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—ALB—liver cancer	1.19e-06	3.73e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—BRAF—liver cancer	1.17e-06	3.68e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—MTHFR—liver cancer	1.17e-06	3.67e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—MTHFR—liver cancer	1.17e-06	3.67e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.16e-06	3.66e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PIK3CD—liver cancer	1.15e-06	3.63e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.15e-06	3.62e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PSMD10—liver cancer	1.15e-06	3.61e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PSMA4—liver cancer	1.15e-06	3.61e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PPARA—liver cancer	1.15e-06	3.6e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PPARA—liver cancer	1.14e-06	3.6e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GSTM1—liver cancer	1.14e-06	3.59e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—ALB—liver cancer	1.14e-06	3.58e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CRABP1—liver cancer	1.14e-06	3.57e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GOT2—liver cancer	1.12e-06	3.51e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—STAT3—liver cancer	1.1e-06	3.45e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—PIK3CD—liver cancer	1.09e-06	3.44e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.09e-06	3.44e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GSTP1—liver cancer	1.08e-06	3.41e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CYP1A1—liver cancer	1.08e-06	3.41e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—SERPINE1—liver cancer	1.08e-06	3.4e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—HMOX1—liver cancer	1.07e-06	3.36e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CYP2E1—liver cancer	1.05e-06	3.3e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PIK3CB—liver cancer	1.05e-06	3.29e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PIK3CG—liver cancer	1.04e-06	3.28e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—MYC—liver cancer	1.02e-06	3.21e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—TGFB1—liver cancer	1.02e-06	3.2e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.02e-06	3.19e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—MTHFR—liver cancer	1.01e-06	3.18e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PIK3CB—liver cancer	1.01e-06	3.16e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PPARG—liver cancer	1.01e-06	3.16e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GSTM1—liver cancer	9.95e-07	3.13e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—HPGDS—liver cancer	9.93e-07	3.12e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PPARA—liver cancer	9.91e-07	3.12e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PIK3CG—liver cancer	9.82e-07	3.09e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CYCS—liver cancer	9.81e-07	3.09e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PIK3CG—liver cancer	9.8e-07	3.08e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—RAF1—liver cancer	9.77e-07	3.07e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GGT1—liver cancer	9.63e-07	3.03e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GOT1—liver cancer	9.63e-07	3.03e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—PIK3CB—liver cancer	9.54e-07	3e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MTOR—liver cancer	9.54e-07	3e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PPARG—liver cancer	9.47e-07	2.98e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PPARG—liver cancer	9.45e-07	2.97e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CYP1A1—liver cancer	9.44e-07	2.97e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—KRAS—liver cancer	9.43e-07	2.97e-05	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PIK3CA—liver cancer	9.26e-07	2.91e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PIK3CD—liver cancer	9.17e-07	2.88e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—ALB—liver cancer	9.05e-07	2.85e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—CDKN1B—liver cancer	8.95e-07	2.82e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	8.9e-07	2.8e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PSMA4—liver cancer	8.85e-07	2.78e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PSMD10—liver cancer	8.85e-07	2.78e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—MTHFR—liver cancer	8.8e-07	2.77e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—PIK3CA—liver cancer	8.67e-07	2.73e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GSTP1—liver cancer	8.65e-07	2.72e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PPARA—liver cancer	8.63e-07	2.71e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PIK3CD—liver cancer	8.63e-07	2.71e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PIK3CD—liver cancer	8.61e-07	2.71e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GOT2—liver cancer	8.61e-07	2.71e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—HMOX1—liver cancer	8.53e-07	2.68e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—ALB—liver cancer	8.52e-07	2.68e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—ALB—liver cancer	8.5e-07	2.67e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PIK3CG—liver cancer	8.48e-07	2.67e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—CTNNB1—liver cancer	8.46e-07	2.66e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—CDKN1A—liver cancer	8.26e-07	2.6e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PPARG—liver cancer	8.19e-07	2.58e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYP2E1—liver cancer	8.09e-07	2.54e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—HRAS—liver cancer	8.02e-07	2.52e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PIK3CB—liver cancer	7.99e-07	2.51e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GSTM1—liver cancer	7.95e-07	2.5e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—IL6—liver cancer	7.67e-07	2.41e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYCS—liver cancer	7.57e-07	2.38e-05	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—AKT1—liver cancer	7.57e-07	2.38e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CYP1A1—liver cancer	7.53e-07	2.37e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PIK3CA—liver cancer	7.53e-07	2.37e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PIK3CB—liver cancer	7.52e-07	2.37e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PIK3CB—liver cancer	7.51e-07	2.36e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PIK3CD—liver cancer	7.46e-07	2.35e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GOT1—liver cancer	7.43e-07	2.34e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GGT1—liver cancer	7.43e-07	2.34e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PIK3CG—liver cancer	7.39e-07	2.32e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—STAT3—liver cancer	7.37e-07	2.32e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—ALB—liver cancer	7.36e-07	2.32e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PIK3CA—liver cancer	7.26e-07	2.28e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PPARG—liver cancer	7.13e-07	2.24e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—AKT1—liver cancer	7.08e-07	2.23e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—MTHFR—liver cancer	7.02e-07	2.21e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PPARA—liver cancer	6.89e-07	2.17e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MYC—liver cancer	6.85e-07	2.15e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—TGFB1—liver cancer	6.83e-07	2.15e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GSTP1—liver cancer	6.67e-07	2.1e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—HMOX1—liver cancer	6.58e-07	2.07e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PIK3CB—liver cancer	6.5e-07	2.04e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PIK3CD—liver cancer	6.5e-07	2.04e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—ALB—liver cancer	6.41e-07	2.02e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PIK3CA—liver cancer	6.39e-07	2.01e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—KRAS—liver cancer	6.33e-07	1.99e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	6.19e-07	1.95e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—AKT1—liver cancer	6.15e-07	1.93e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PIK3CA—liver cancer	6.14e-07	1.93e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GSTM1—liver cancer	6.13e-07	1.93e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—AKT1—liver cancer	5.93e-07	1.86e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PIK3CG—liver cancer	5.9e-07	1.86e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—PIK3CA—liver cancer	5.82e-07	1.83e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYP1A1—liver cancer	5.81e-07	1.83e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PPARG—liver cancer	5.7e-07	1.79e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PIK3CB—liver cancer	5.66e-07	1.78e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—MTHFR—liver cancer	5.42e-07	1.7e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—HRAS—liver cancer	5.38e-07	1.69e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PPARA—liver cancer	5.32e-07	1.67e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—AKT1—liver cancer	5.22e-07	1.64e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PIK3CD—liver cancer	5.19e-07	1.63e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—IL6—liver cancer	5.15e-07	1.62e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ALB—liver cancer	5.12e-07	1.61e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—AKT1—liver cancer	5.01e-07	1.58e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PIK3CA—liver cancer	4.87e-07	1.53e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—AKT1—liver cancer	4.75e-07	1.49e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PIK3CA—liver cancer	4.59e-07	1.44e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PIK3CA—liver cancer	4.58e-07	1.44e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PIK3CG—liver cancer	4.55e-07	1.43e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PIK3CB—liver cancer	4.52e-07	1.42e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PPARG—liver cancer	4.4e-07	1.38e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PIK3CD—liver cancer	4e-07	1.26e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—AKT1—liver cancer	3.98e-07	1.25e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PIK3CA—liver cancer	3.96e-07	1.25e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ALB—liver cancer	3.95e-07	1.24e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—AKT1—liver cancer	3.75e-07	1.18e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—AKT1—liver cancer	3.74e-07	1.18e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PIK3CB—liver cancer	3.49e-07	1.1e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PIK3CA—liver cancer	3.45e-07	1.09e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—AKT1—liver cancer	3.24e-07	1.02e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—AKT1—liver cancer	2.82e-07	8.87e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PIK3CA—liver cancer	2.76e-07	8.67e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—AKT1—liver cancer	2.25e-07	7.08e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PIK3CA—liver cancer	2.13e-07	6.69e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—AKT1—liver cancer	1.74e-07	5.46e-06	CbGpPWpGaD
